摘要
目的评价短期内应用雷贝拉唑与铝碳酸镁治疗对十二指肠溃疡(DU)患者症状的治疗作用及安全。方法将DU患者随机分为雷贝拉唑治疗组与铝碳酸镁对照组,均服药7d。对比两者治疗前后的各种症状。结果短期治疗后,治疗组疗效明显高于对照组疗效。结论雷贝拉唑与铝碳酸镁对DU均有较好的治疗效果,而雷贝拉唑短期应用具有更好的疗效和安全性。
Objective To evaluate the short-term internal help to use the treatment function and safeties that the Rabeprazole and the aluminum carbonic acid magnesium treatments to 12 bowels(DU) sufferer's symptoms. Methods The sufferers of DU is divided random into the Rabeprazole treatment set and the aluminum carbonic acid magnesium matched controls,all taking the medicine 7 d.Contrast both cure in front and back various symptom. Results After short date cure,treatment a curative effect obvious high in the curative effect of the matched control. Conclusions The Rabeprazole and the aluminum carbonic acid magnesiums to all compare to the DU good of treatment result,but the Rabeprazole short date application to have the better curative effect and safeties.
出处
《中国医药导报》
CAS
2006年第11期61-62,共2页
China Medical Herald
关键词
雷贝拉唑
铝碳酸镁
DU
对照研究
Rabeprazole
the aluminum carbonic acid magnesium
DU
check against the research